Sun-Hye Lee

Sun-Hye Lee

Auto-generated profile, based on publicly available information

Sun-Hye Lee

Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon, Gyeonggi-do 420-767 South Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
SLSun-Hye Lee
Sun-Hye Lee
PLPureun-Haneul Lee
Pureun-Haneul Lee
BKByeong-Gon Kim
Byeong-Gon Kim
HSHyun-Jeong Seo
Hyun-Jeong Seo
ABAe-Rin Baek
Ae-Rin Baek
AJAn-Soo Jang
An-Soo Jang
Annexin-A1 (ANXA1) is a glucocorticoid-induced protein with multiple actions in the regulation of inflammatory cell activation. The anti-inflammatory protein ANXA1 and its N-formyl peptide receptor 2 (FPR2) have protective effects on organ fibrosis. However, the exact role of ANXA1 in asthma remains to be determined. The aim of this study was to identify the role of ANXA1 in bronchial asthma. In mice sensitized and challenged with ovalbumin (OVA-OVA mice) and mice sensitized with saline and challenged with air (control mice), we investigated the potential links between ANXA1 levels and bronchial asthma using ELISA, immunoblotting, and immunohistochemical staining. Moreover, we also determined ANXA1 levels in blood from 50 asthmatic patients (stable and exacerbated states). ANXA1 protein levels in lung tissue and bronchoalveolar lavage fluid were significantly higher in OVA-OVA mice compared with control mice. FPR2 protein levels in lung tissue were significantly higher in OVA-OVA mice compared with control mice. Plasma ANXA1 levels were increased in asthmatic patients compared with healthy controls. Plasma ANXA1 levels were significantly lower in exacerbated patients compared with stable patients with bronchial asthma (p < 0.05). The plasma ANXA1 levels in controlled asthmatic patients were correlated with forced expiratory volume in 1 s (FEV1) (r = − 0.191, p = 0.033) and FEV1/forced vital capacity (FVC) (r = −0.202, p = 0.024). These results suggest that ANXA1 may be a potential marker and therapeutic target for asthma.

1 January 2018 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
BKByeong-Gon Kim
Byeong-Gon Kim
PLPureun-Haneul Lee
Pureun-Haneul Lee
SLSun-Hye Lee
Sun-Hye Lee
ABAe-Rin Baek
Ae-Rin Baek
JPJong-Sook Park
Jong-Sook Park
AJAn-Soo Jang
An-Soo Jang
Kim BG, et al. Allergy Asthma Immunol Res. 2018 Sep;10(5):533-542. https://doi.org/10.4168/aair.2018.10.5.533

17 January 2018 in Proteome Science
Verified
Journal Article
Open access
PDF file
PLPureun-Haneul Lee
Pureun-Haneul Lee
BKByeong-Gon Kim
Byeong-Gon Kim
SLSun-Hye Lee
Sun-Hye Lee
GLGeorge D. Leikauf
George D. Leikauf
AJAn-Soo Jang
An-Soo Jang
Acrolein (allyl Aldehyde) as one of smoke irritant exacerbates chronic airway diseases and increased in sputum of patients with asthma and chronic obstructive lung disease. But underlying mechanism remains unresolved. The aim of study was to identify protein expression in human lung microvascular endothelial cells (HMVEC-L) exposed to acrolein. A proteomic approach was used to determine the different expression of proteins at 8 h and 24 h after treatment of acrolein 30 nM and 300 nM to HMVEC-L. Treatment of HMVEC-L with acrolein 30 nM and 300 nM altered 21 protein spots on the two-dimensional gel, and these were then analyzed by MALDI-TOF MS. These proteins included antioxidant, signal transduction, cytoskeleton, protein transduction, catalytic reduction. The proteins were classified into four groups according to the time course of their expression patterns such as continually increasing, transient increasing, transient decreasing, and continually decreasing. For validation immunohistochemical staining and Western blotting was performed on lung tissues from acrolein exposed mice. Moesin was expressed in endothelium, epithelium, and inflammatory cells and increased in lung tissues of acrolein exposed mice compared with sham treated mice. These results indicate that some of proteins may be an important role for airway disease exacerbation caused by acrolein exposure.